Improving Obesity Care: A Practical Guide to Engaging and Treating Patients- Webcast

Webcast Session

This course was a live CME-certified Ancillary Symposium presented at Endocrine Society Annual Meeting (ENDO) 2018, held in Chicago, IL.This educational activity is supported by an independent medical educational grant from Novo Nordisk Inc. 

Preview

PLEASE REGISTER THEN CLICK "START" TO EVALUATE SESSIONS, CLAIM CME, AND PRINT A CME CERTIFICATE OR CERTIFICATE OF PARTICIPATION.

Target Audience

This activity is intended for endocrinologists and endocrine fellows, primary care physicians, physician’s assistants, nurse practitioners and other healthcare professionals.

Learning Objectives

Upon completion of this educational activity, learners will be able to:
  • Incorporate key measures and updated algorithms for risk when assessing patients for obesity and its comorbidities
  • Recognize obesity as a disease and understand associated barriers to initiating and maintaining care
  • Evaluate and apply intensive lifestyle interventions that take effectiveness, access to support, and patient preference into consideration
  • Apply evidence-based guidelines in the selection and use of pharmacotherapy to treat patients with obesity that takes risk factors into consideration
  • Devise patient-centered strategies to overcome challenges in long-term weight loss maintenance

Additional Information

Target Audience: 
Physician-in-practice
Fellow
Resident
Clinical researcher
Scientific researcher
Educator/Teacher
Pharmacist
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Other
Competency Area: 
Professionalism
Patient Care and Procedural Skills
Medical Knowledge
Topic Area: 
Obesity
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Level 3B (Learning: Procedural Knowledge (Knows How))
Level 4 (Learning: Competence (Shows How))
Level 5 (Performance (Does))
Activity summary
Available credit: 
  • 2.50 ABIM MOC
  • 2.50 AMA PRA Category 1 Credits
  • 2.50 CME Certificate of Participation
Course opens: 
04/05/2018
Course expires: 
04/30/2019
Rating: 
0

Program Chair
Robert F. Kushner, MD, MS 
Northwestern University Feinberg School of Medicine
Medical Director
Center for Lifestyle Medicine, Northwestern Medicine
Chicago, IL

Faculty
W. Timothy Garvey, MD

Butterworth Professor and Chair, Department of Nutrition Sciences
Director, UAB Diabetes Research Center
Associate Director, UAB Nutrition Obesity Research Center
GRECC Investigator & Staff Physician, Birmingham VAMC
University of Alabama at Birmingham
Birmingham, AL

Scott Kahan, MD, MPH
George Washington University School of Medicine and Milken Institute School of Public Health
Johns Hopkins Bloomberg School of Public Health
Washington, DC

Donna H. Ryan, MD
Professor Emerita
Pennington Biomedical Research Center
Baton Rouge, LA

DISCLOSURE POLICY

he faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships during the content development process for this activity: 
Robert F. Kushner, MD, MS

The faculty reported the following relevant financial relationship(s) during the content development process for this activity:
W. Timothy Garvey, MD: Advisory Board Member, Janssen Research & Development Company, Takeda, Novo Nordisk, Alexion Pharmaceuticals, Inc., AstraZeneca, Merck; Grant Recipient, Pfizer, Inc., Novo Nordisk, Merck
Scott Kahan, MD, MPH: Consultant, Novo Nordisk; Speaker, Novo Nordisk
Donna H. Ryan, MD: Advisory Board, Novo Nordisk, Real Appeal, Sanofi, Gila Therapeutics, Orexigen, Scientific Intake; Consultant, Janssen Research & Development Company, Merck, Orexigen; Speaker, Novo Nordisk, Orexigen, Eisai

The following SPC member who planned and reviewed content for this activity reported no relevant financial relationships: 
Amy Rothberg, MD


The following SPC members reported relevant financial relationships:
Zahid Ahmad, MD: Research Support, Regeneron, FH Foundation; Consultant, Regeneron; Speaker, Amgen, Genzyme, Sanofi
Andrew Ahmann, MD: Research Support, DexCom, Lexicon, Medtronic, Novo Nordisk; Consultant, Dexcom, Novo Nordisk, Trividia Health
Giuseppe Barbesino, MD: Spouse, employee of Genzyme
John Carmichael, MD: Research Support, Novo Nordisk, Chiasma, Novartis, Pfizer, Strongbridge Biopharma; Speaker, Novartis; Advisory Board, Pfizer, Chiasma, Ionis Pharmaceuticals
Natalie Cusano, MD: Research Support, Shire; Speaker, Shire
Joan Han, MD: Research Support, Rhythm Pharmaceutical
Steven T. Harris, MD: Ad hoc consultant on Advisory Boards, Eli Lilly & Company, Merck, Radius Health; Speaker, Amgen, Eli Lilly & Company, Radius Health, Shire
Alan Kelly, MD: Speaker, Eli Lilly
Jonathan Purnell, MD: Advisor, Novo Nordisk
Neda Rasouli, MD: Research Support, Novo Nordisk, Calibra, INTARCIA Therapeutics, GlaxoSmithKline, Bristol Meyer Squibb, AstraZeneca /Amylin, Ionis Pharmaceuticals, Boehringer Ingelheim

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.

The following SPC members reported no relevant financial relationships:
Susmeeta Sharma, MD

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

Click "Start" to complete meeting evaluation, claim CME, and print a certificate of attendance or certificate of participation.
 
The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.
 
The Endocrine Society designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credit™ and 2.5 ABIM MOC Points. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
For questions about content or obtaining CME credit, please contact the Endocrine Society at education.endocrine.org/contact
 
 

Review your Diplomate ABIM ID Number(s)

In order to earn and report MOC points to the American Board of Internal Medicine (ABIM), you must:

  1. Provide your board-certification information in your educational profile.  Your profile currently contains the following board ID numbers (must be logged in to view):

    Your ABIM Number: [current-user:profile-profile:field-number-abim]*

    *If your ABIM number is blank or incorrect as shown above, please click the Update Profile button below to add or correct your profile.

  2. Update Profile

Available Credit

  • 2.50 ABIM MOC
  • 2.50 AMA PRA Category 1 Credits
  • 2.50 CME Certificate of Participation

Accreditation Period

Course opens: 
04/05/2018
Course expires: 
04/30/2019